CN1718244A - Activated carbon external application antiphlogistine, and its prepn. method - Google Patents
Activated carbon external application antiphlogistine, and its prepn. method Download PDFInfo
- Publication number
- CN1718244A CN1718244A CN 200510031630 CN200510031630A CN1718244A CN 1718244 A CN1718244 A CN 1718244A CN 200510031630 CN200510031630 CN 200510031630 CN 200510031630 A CN200510031630 A CN 200510031630A CN 1718244 A CN1718244 A CN 1718244A
- Authority
- CN
- China
- Prior art keywords
- activated carbon
- external application
- antiphlogistine
- host material
- inflammatory drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
An exterior-applied anti-inflammatory ointment for treating the inflammatory wound is prepared from granular activated carbon (10-80%), antibacterial and anti-inflammatory medicine (5-20%) and matrix (10-80%) through sequential mixing and stirring.
Description
Technical field
The present invention relates to a kind of external application antibiosis anti-inflammatory drug.
Background technology
Present employed external application antibiosis anti-inflammatory drug all is to be mixed by antibiosis anti-inflammatory drug and host material, because host material all is butyrous mostly, when outside when being applied to inflamed wound, because inflamed wound has big quantity of fluid to ooze out, make antibiosis anti-inflammatory drug directly not touch inflamed wound, influenced the effect of antibiosis anti-inflammatory drug, make the inflamed wound healing slow, even antibiosis anti-inflammatory drug is polluted wound circumference along with wound fluid flows to wound circumference.
Summary of the invention
The objective of the invention is effective external application antibiosis anti-inflammatory drug.
The objective of the invention is to realize in the following way: a kind of activated carbon external application antiphlogistine, be made up of following component: particle diameter is 100-800 order activated carbon 10-80%, host material 10-80%, antibiosis anti-inflammatory drug 5-20%.
Host material is any in vaseline, liquid Paraffin, lanocerin, Cera Flava, vegetable oil, glyceryl monostearate, high-carbon fatty alcohol, Polyethylene Glycol, glycerinum amyli, glycerin gelatine, sodium carboxymethyl cellulose, the sucrose fatty acid ester.
A kind of preparation method of activated carbon external application antiphlogistine: earlier nano active carbon is mixed with antibiosis anti-inflammatory drug, add host material again, fully stir mix homogeneously.
The present invention has following beneficial effect, because activated carbon has very strong adsorptivity, when outside when being applied to inflamed wound, can be attached on the inflamed wound, simultaneously can absorb the liquid that inflamed wound is oozed out again, the drying that keeps inflamed wound strengthens the antiphlogistic antibacterial effect of antibiosis anti-inflammatory drug greatly, accelerates the healing of inflamed wound.
The specific embodiment
The present invention will be further described below in conjunction with specific embodiment:
Embodiment one,
Getting particle diameter is 300 purpose activated carbon 60%, after chloromycetin 15% fully mixes, adds vaseline 35, fully stir, mix homogeneously is made chloromycetin ointment, be used for small size burn and scald wound external application anti-inflammation, the drug level height, long action time is coated in the wound surface, once-a-day, wound does not have transudate, promotes the dry incrustation of wound, and wound healing is good.
Embodiment two,
Getting particle diameter is 200 purpose activated carbon 20%, after erythromycin 10% fully mixes, add lanoline 70, fully stir, mix homogeneously is made erythromycin ointment, be used for that the dense sexuality of facial skinization is dyed, folliculitis, conjunctivitis etc., be coated in the inflammation skin surface, zest is less, healing back skin preventing from scar.
Embodiment three,
Getting particle diameter is 400 purpose activated carbon 50%, with medicinal sulfur 10%, Borax 10%, after fully mixing, adds lanoline 30, fully stirs, and mix homogeneously is made sulfur Borax emulsifiable paste, is used for the external preparation for skin parasite killing.
Claims (3)
1, a kind of activated carbon external application antiphlogistine, be made up of following component: particle diameter is 100-800 purpose activated carbon 10-80%, host material 10-80%, antibiosis anti-inflammatory drug 5-20%.
2, activated carbon external application antiphlogistine according to claim 1 is characterized in that: host material is any in vaseline, liquid Paraffin, lanocerin, Cera Flava, vegetable oil, glyceryl monostearate, high-carbon fatty alcohol, Polyethylene Glycol, glycerinum amyli, glycerin gelatine, sodium carboxymethyl cellulose, the sucrose fatty acid ester.
3, the preparation method of activated carbon external application antiphlogistine according to claim 1: it is characterized in that: earlier activated carbon is mixed with antibiosis anti-inflammatory drug, add host material again, fully stir mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510031630 CN1718244A (en) | 2005-05-28 | 2005-05-28 | Activated carbon external application antiphlogistine, and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510031630 CN1718244A (en) | 2005-05-28 | 2005-05-28 | Activated carbon external application antiphlogistine, and its prepn. method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1718244A true CN1718244A (en) | 2006-01-11 |
Family
ID=35930272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510031630 Pending CN1718244A (en) | 2005-05-28 | 2005-05-28 | Activated carbon external application antiphlogistine, and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1718244A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031064A (en) * | 2015-05-29 | 2015-11-11 | 柳州市妇幼保健院 | Homemade cream for preventing neonatal red buttock and its preparing method |
| CN106309489A (en) * | 2016-09-28 | 2017-01-11 | 贵州特力达纳米碳素科技有限公司 | Medicinal patch for diminishing skin inflammation, and preparation method thereof |
-
2005
- 2005-05-28 CN CN 200510031630 patent/CN1718244A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031064A (en) * | 2015-05-29 | 2015-11-11 | 柳州市妇幼保健院 | Homemade cream for preventing neonatal red buttock and its preparing method |
| CN106309489A (en) * | 2016-09-28 | 2017-01-11 | 贵州特力达纳米碳素科技有限公司 | Medicinal patch for diminishing skin inflammation, and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bajpai et al. | Nano cellulose dispersed chitosan film with Ag NPs/Curcumin: An in vivo study on Albino Rats for wound dressing | |
| US9855309B2 (en) | Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith | |
| Huang et al. | Multifunctional bioactive core-shell electrospun membrane capable to terminate inflammatory cycle and promote angiogenesis in diabetic wound | |
| Liu et al. | Janus hydrogel with dual antibacterial and angiogenesis functions for enhanced diabetic wound healing | |
| CN103320967B (en) | Composite electrostatic spinning material containing fullerene and nano-silver for medical dressings and method for manufacturing composite electrostatic spinning material | |
| US20200129654A1 (en) | Dressing Providing for the Controlled and Sustained Release of Metformin | |
| CN100411690C (en) | Bacteriostatic porous polyelectrolyte material and its prepn process | |
| Kanu et al. | Electrospinning process parameters optimization for biofunctional curcumin/gelatin nanofibers | |
| EP2253665A1 (en) | Freeze-dried composition | |
| EP2274020B1 (en) | Skin or wound dressing for moist wound healing | |
| Liu et al. | Advances in the preparation of nanofiber dressings by electrospinning for promoting diabetic wound healing | |
| CN101461535A (en) | Method for preparing antioxidation gelatine membrane containing tea polyphenol-chitosan nano grain | |
| Abbas et al. | Chitosan-polyvinyl alcohol membranes with improved antibacterial properties contained Calotropis procera extract as a robust wound healing agent | |
| EP2104519B1 (en) | Film-forming gel composition for wound or skin care | |
| Deng et al. | Double-network hydrogel enhanced by SS31-loaded mesoporous polydopamine nanoparticles: Symphonic collaboration of near-infrared photothermal antibacterial effect and mitochondrial maintenance for full-thickness wound healing in diabetes mellitus | |
| CN106620813A (en) | Preparation method of medical anti-microbial nanometer dressing | |
| Chen et al. | A quaternized chitosan and carboxylated cellulose nanofiber-based sponge with a microchannel structure for rapid hemostasis and wound healing | |
| CN1718244A (en) | Activated carbon external application antiphlogistine, and its prepn. method | |
| Prasad et al. | An injectable self-healing anesthetic glycolipid-based oleogel with antibiofilm and diabetic wound skin repair properties | |
| CN103436992B (en) | Method for preparing nano drug-carrying capsule-loaded alginate fibers | |
| US11191866B2 (en) | Dressing enabling the controlled and prolonged release of metformin | |
| Muthulakshmi et al. | In vivo wound healing efficiency of curcumin-incorporated pectin-chitosan biodegradable films | |
| CN105287667A (en) | Traditional Chinese medicine liquid patch for treating arthritis and rheumatism | |
| CN1216593C (en) | Liquid wound plaster and its preparing method | |
| CN113995736A (en) | Radix tetrastigme spray film agent for wound healing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |